Overview
Pamela S Douglas MD is the Ursula Geller Professor of Research in Cardiovascular Diseases in the Department of Medicine at Duke University and Director of the Multimodality Imaging Program at Duke Clinical Research Institute. During her 30+ years of experience she has led several landmark multicenter government studies and pivotal industry clinical trials along with outcomes research studies. She is renowned for her scientific and policy work in improving the quality and appropriateness of imaging in clinical care, clinical trials and registries and through development and dissemination of national standards for imaging utilization, informatics and analysis. She has been among the pioneers in a number of areas including heart disease in women, sports cardiology, and cardio-oncology. Dr. Douglas’ wealth of experience includes authorship of over 400 peer reviewed manuscripts and 30 practice guidelines, and service as the President of the American College of Cardiology, President of the American Society of Echocardiography, and Chief of Cardiology at both the University of Wisconsin and Duke University. She has also previously served on the faculties of the University of Pennsylvania and Harvard University. She currently serves on the External Advisory Council of the National Heart, Lung and Blood Institute and the Scientific Advisory Board of the Patient Advocate Foundation.
Current Appointments & Affiliations
Recent Publications
Association Between Predicting Risk of Cardiovascular Disease Events (PREVENT) Risk Scores and Subclinical Cardiovascular Disease: Insights From the Project Baseline Health Study.
Journal Article J Am Heart Assoc · May 29, 2026 BACKGROUND: The American Heart Association Predicting Risk of Cardiovascular Disease Events risk scores estimate cardiovascular disease (CVD) risk, including heart failure (HF) and atherosclerotic CVD (ASCVD) events. Whether they associate with subclinical ... Full text Link to item CitePrimary Prevention for People Living With HIV: A Call to Action.
Journal Article J Am Coll Cardiol · May 19, 2026 Full text Link to item CiteImpact of the 2025 ASE Guidelines on the Classification of LV Diastolic Dysfunction in the Community: A Project Baseline Health Study.
Journal Article Circ Cardiovasc Imaging · May 14, 2026 BACKGROUND: The 2016 American Society of Echocardiography (ASE) guidelines for left ventricular diastolic dysfunction (LVDD) classification resulted in a significant proportion of indeterminate classifications and grades. To address these limitations and i ... Full text Link to item CiteRecent Grants
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
ResearchCo Investigator · Awarded by NYU Langone Medical Center · 2023 - 20281/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2027Pericoronary adipose tissue density a novel CT-derived marker of local inflammation and coronary artery disease in patients living with HIV
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2023 - 2027View All Grants